BIT 0.00% 3.6¢ biotron limited

Is this the sort of deal Michelle might chase? Thinking more...

  1. J8
    14,521 Posts.
    lightbulb Created with Sketch. 816
    Is this the sort of deal Michelle might chase? Thinking more along the HIV front for outside interest in BIT225.



    Johnson & Johnson ($JNJ) has deepened its ties to regenerative medicine outfit ViaCyte, handing the biotech $20 million in exchange for a future stake in the company and the right to acquire its in-development diabetes medication. Under the deal, J&J's cash buys it a note convertible into equity and an exclusive chance to acquire VC-01, ViaCyte's stem cell-derived treatment for Type 1 diabetes.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
0.000(0.00%)
Mkt cap ! $32.48M
Open High Low Value Volume
3.6¢ 3.6¢ 3.6¢ $20.79K 577.4K

Buyers (Bids)

No. Vol. Price($)
1 76422 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.7¢ 123461 1
View Market Depth
Last trade - 10.01am 27/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.